Previous studies have identified the HCST as a key immune-related gene involved in m6A regulator-mediated RNA methylation modification patterns in AF, suggesting its potential value as an intervention target in the AF immune microenvironment under the COVID-19 burden [39,40]. Here, HCST is linked to atrial fibrillation.